Gene · 7296
Papers4,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 4,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Design, Synthesis, and Bioactivity Evaluations of 3-Methylenechroman-2-one Derivatives as Thioredoxin Reductase (TrxR) Inhibitors. | ChemMedChem | 2024 | 38063319 | PubTator, text mining | PubMed |
| Multi-omics analyses reveal bacteria and catalase associated with keloid disease. | EBioMedicine | 2024 | 38061241 | PubTator, text mining | PubMed |
| Metabolic Enzyme SLC27A5 Regulates PIP4K2A pre-mRNA Splicing as a Noncanonical Mechanism to Suppress Hepatocellular Carcinoma Metastasis. | Adv Sci (Weinh) | 2024 | 38059827 | PubTator, text mining | PubMed |
| Fingerprint of the oxido-reductase ERO1: A protein disulfide bond producer and supporter of cancer. | Biochim Biophys Acta Rev Cancer | 2024 | 38007054 | PubTator, text mining | PubMed |
| Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments. | Am J Clin Dermatol | 2024 | 37717255 | PubTator, text mining | PubMed |
| Antiproliferative, antimigratory, and apoptotic effects of diffractaic and vulpinic acids as thioredoxin reductase 1 inhibitors on cervical cancer. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | 37658214 | PubTator, text mining | PubMed |
| Novel Insights on Ferroptosis Modulation as Potential Strategy for Cancer Treatment: When Nature Kills. | Antioxid Redox Signal | 2024 | 37132605 | PubTator, text mining | PubMed |
| Distinct or Overlapping Areas of Mitochondrial Thioredoxin 2 May Be Used for Its Covalent and Strong Non-Covalent Interactions with Protein Ligands. | Antioxidants (Basel) | 2023 | 38275635 | PubTator, text mining | PubMed |
| Glucose oxidase-instructed biomineralization of calcium-based biomaterials for biomedical applications. | Exploration (Beijing) | 2023 | 38264686 | PubTator, text mining | PubMed |
| Oxidative Stress and Cancer: Harnessing the Therapeutic Potential of Curcumin and Analogues Against Cancer. | Eur J Biol | 2023 | 38264081 | PubTator, text mining | PubMed |
| Carnosol ameliorated cancer cachexia-associated myotube atrophy by targeting P5CS and its downstream pathways. | Front Pharmacol | 2023 | 38249348 | PubTator, text mining | PubMed |
| Prediction of Chemoresistance-How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer. | Curr Oncol | 2023 | 38248100 | PubTator, text mining | PubMed |
| Oxidative Stress in Parasitic Diseases-Reactive Oxygen Species as Mediators of Interactions between the Host and the Parasites. | Antioxidants (Basel) | 2023 | 38247462 | PubTator, text mining | PubMed |
Diverse and Synergistic Actions of Phytochemicals in a Plant-Based Multivitamin/Mineral Supplement against Oxidative Stress and Inflammation in Healthy Individuals: A Systems Biology Approach Based on a Randomized Clinical Trial. | Antioxidants (Basel) | 2023 | 38247460 | PubTator, text mining | PubMed |
| Recent advances in natural compounds inducing non-apoptotic cell death for anticancer drug resistance. | Cancer Drug Resist | 2023 | 38239395 | PubTator, text mining | PubMed |
| Comparison of software packages for detecting unannotated translated small open reading frames by Ribo-seq. | bioRxiv | 2023 | 38234848 | PubTator, text mining | PubMed |
| An Overview of the Occurrence of Bioactive Peptides in Different Types of Cheeses. | Foods | 2023 | 38231707 | PubTator, text mining | PubMed |
| Enhanced drug delivery and wound healing potential of berberine-loaded chitosan-alginate nanocomposite gel: characterization and in vivo assessment. | Front Public Health | 2023 | 38229669 | PubTator, text mining | PubMed |
| Redox Biology and Liver Fibrosis. | Int J Mol Sci | 2023 | 38203581 | PubTator, text mining | PubMed |
| Biosynthesis, Engineering, and Delivery of Selenoproteins. | Int J Mol Sci | 2023 | 38203392 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7296/papers?page=21